Ultrastructural injury of arterial endothelium. II. Effects of vasoactive amines.
D000588:Amines / Q000494:pharmacology*; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001158:Arteries / Q000187:drug effects / Q000473:pathology*; D001920:Bradykinin / Q000494:pharmacology; D002462:Cell Membrane; D002712:Chlorides / Q000494:pharmacology; D002714:Chlorisondamine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D004848:Epithelium / Q000473:pathology; D007083:Iliac Artery / Q000473:pathology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008854:Microscopy, Electron; D010477:Perfusion; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology*; D014439:Tyramine / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D000588:Amines; D002712:Chlorides; D011437:Propylamines; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D012701:Serotonin; D002714:Chlorisondamine; D007545:Isoproterenol; D001920:Bradykinin; D004298:Dopamine; D014439:Tyramine; D004837:Epinephrine